Savara, Inc. (SVRA) Financials
SVRA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 177.6 million | 37.2 million |
2023-09-30 | 182.1 million | 35.5 million |
2023-06-30 | 119.8 million | 32.1 million |
2023-03-31 | 129.4 million | 31.1 million |
SVRA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -15.6 million | 1.4 million |
2023-09-30 | -13.2 million | 995000 |
2023-06-30 | -10.5 million | 958000 |
2023-03-31 | -12.0 million | 864000 |
SVRA Net Income
No data available :(
SVRA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 162.3 million | - | 143000 |
2023-09-30 | 168.3 million | - | 139000 |
2023-06-30 | 105.2 million | - | 67000 |
2023-03-31 | 114.8 million | 26.1 million | 65000 |
SVRA Shares Outstanding
SVRA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 24000 | 12.7 million | 4.9 million | 34000 |
2023-09-30 | 43000 | 13.9 million | 4.1 million | - |
2023-06-30 | 225000 | 8.9 million | 3.3 million | - |
2023-03-31 | 4000 | 8.7 million | 3.4 million | - |
SVRA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 66000 |
2023-09-30 | - | 63000 |
2023-06-30 | - | 24000 |
2023-03-31 | - | 23000 |
SVRA
Price: $4.68
52 week price:
Earnings Per Share: -0.33 USD
P/E Ratio: -15.65
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 765007
Ebitda: -6.6 millionMarket Capitalization: 700.4 million